The Role of MicroRNAs in Breast Cancer.

J Assoc Genet Technol

Molecular Pathology, Dept of Laboratory Sciences and Primary Care, Texas Tech University Health Sciences Center at Lubbock, TX.

Published: July 2011

Breast cancer is the most common form of cancer in women. Despite extensive study, the etiology of breast cancer remains ambiguous. A group of genetic modifiers known as microRNAs (miRNAs) are emerging onto the scene of breast cancer research. MicroRNAs are small, non-coding RNAs that are involved in the regulation of key cellular processes such as proliferation, differentiation, and apoptosis. They can interfere directly with the translation and stability of a targeted gene transcript and cause a disturbance in the cell physiology. The dysregulation of both oncogenes and tumor suppressor genes by aberrant miRNA production can result in the progression to breast cancer. This review provides a discussion of the nature of miRNAs, explains the role of miRNAs in the etiology and progression of breast cancer, and discusses their potentials as therapeutic molecules and diagnostic markers.

Download full-text PDF

Source

Publication Analysis

Top Keywords

breast cancer
24
progression breast
8
cancer
7
breast
6
role micrornas
4
micrornas breast
4
cancer breast
4
cancer common
4
common form
4
form cancer
4

Similar Publications

A common digestive system cancer with a dismal prognosis and a high death rate globally is breast cancer (BRCA). BRCA recurrence, metastasis, and medication resistance are all significantly impacted by cancer stem cells (CSCs). However, the relationship between CSCs and the tumor microenvironment in BRCA individuals remains unknown, and this information is critically needed.

View Article and Find Full Text PDF

Purpose: Age stratification influences the clinicopathological features and survival outcomes of breast cancer. We aimed to understand the effect of age on gene variants in young Chinese women with breast cancer compared with those from The Cancer Genome Atlas (TCGA).

Methods: Enrolled patients ≤ 40 years old (N = 370) underwent germline or somatic genetic testing using a 32-gene hereditary cancer panel at Fujian Union Hospital.

View Article and Find Full Text PDF

Purpose: There is an increasing incidence of young breast cancer (YBC) patients with uncertainty surrounding the factors and patterns that are contributing.

Methods: We obtained characteristics and survival data from 206,156 YBC patients (≤ 40 years of age) diagnosed between 2005 and 2019 from the National Cancer Database (NCDB). Patients were subdivided into two comparison groups based on year of diagnosis (2005-2009, Old vs.

View Article and Find Full Text PDF

Hydrogen sulfide (HS)-mediated protein S-sulfhydration has been shown to play critical roles in several diseases. Tumor-associated macrophages (TAMs) are the predominant population of immune cells present within solid tumor tissues, and they function to restrict antitumor immunity. However, no previous study has investigated the role of protein S-sulfhydration in TAM reprogramming in breast cancer (BC).

View Article and Find Full Text PDF

Background: Bilateral risk-reducing mastectomies (RRMs) have been proven to decrease the risk of breast cancer in patients at high risk owing to family history or having pathogenic genetic mutations. However, few resources with consolidated data have detailed the patient experience following surgery. This systematic review features patient-reported outcomes for patients with no breast cancer history in the year after their bilateral RRM.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!